These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8410970)

  • 61. D-amino acid scan of endothelin: importance of amino acids adjacent to cysteinyl residues in isomeric selectivity.
    Galantino M; de Castiglione R; Cristiani C; Vaghi F; Liu W; Zhang JW; Tam JP
    Pept Res; 1995; 8(3):154-9. PubMed ID: 7670230
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lysine 182 of endothelin B receptor modulates agonist selectivity and antagonist affinity: evidence for the overlap of peptide and non-peptide ligand binding sites.
    Lee JA; Brinkmann JA; Longton ED; Peishoff CE; Lago MA; Leber JD; Cousins RD; Gao A; Stadel JM; Kumar CS
    Biochemistry; 1994 Dec; 33(48):14543-9. PubMed ID: 7981216
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of endothelins in regulation of vascular tone in the in situ perfused rat adrenals.
    Mazzocchi G; Malendowicz LK; Musajo FG; Gottardo G; Markowska A; Nussdorfer GG
    Am J Physiol; 1998 Jan; 274(1):E1-5. PubMed ID: 9458740
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype.
    Heyl DL; Cody WL; He JX; Flynn MA; Welch KM; Reynolds EE; Doherty AM
    Pept Res; 1993; 6(5):238-41. PubMed ID: 8257799
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
    Allcock GH; Warner TD
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S177-9. PubMed ID: 8587355
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
    Semler DE; Ohlstein EH; Nambi P; Slater C; Stern PH
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1052-8. PubMed ID: 7891315
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selective ET(A) antagonists. 5. Discovery and structure-activity relationships of phenoxyphenylacetic acid derivatives.
    Astles PC; Brown TJ; Halley F; Handscombe CM; Harris NV; Majid TN; McCarthy C; McLay IM; Morley A; Porter B; Roach AG; Sargent C; Smith C; Walsh RJ
    J Med Chem; 2000 Mar; 43(5):900-10. PubMed ID: 10715156
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and structure-activity relationships of 2-substituted D-tryptophan-containing peptidic endothelin receptor antagonists: importance of the C-2 substituent of the D-tryptophan residue for endothelin A and B receptor subtype selectivity.
    Fukami T; Yamakawa T; Niiyama K; Kojima H; Amano Y; Kanda F; Ozaki S; Fukuroda T; Ihara M; Yano M; Ishikawa K
    J Med Chem; 1996 Jun; 39(12):2313-30. PubMed ID: 8691426
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endothelin receptor subtypes in resistance arteries from humans and rats.
    Deng LY; Li JS; Schiffrin EL
    Cardiovasc Res; 1995 Apr; 29(4):532-5. PubMed ID: 7796447
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
    Widdowson PS; Kirk CN
    Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structure-activity analysis of C-terminal endothelin analogues.
    Rovero P; Galoppini C; Laricchia-Robbio L; Mazzoni MR; Revoltella RP
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S251-4. PubMed ID: 9595452
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Important role of C-terminal peptide bonds for endothelin receptor binding and activity.
    Olsen UB; Weis JU; Suzdak P; Lundt BF; Madsen K; Thøgersen H; Johansen NL
    Pharmacol Toxicol; 1993 Jul; 73(1):60-2. PubMed ID: 8234195
    [No Abstract]   [Full Text] [Related]  

  • 74. The structure and specificity of endothelin receptors: their importance in physiology and medicine.
    Huggins JP; Pelton JT; Miller RC
    Pharmacol Ther; 1993; 59(1):55-123. PubMed ID: 8259382
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonists.
    Murugesan N; Gu Z; Stein PD; Spergel S; Mathur A; Leith L; Liu EC; Zhang R; Bird E; Waldron T; Marino A; Morrison RA; Webb ML; Moreland S; Barrish JC
    J Med Chem; 2000 Aug; 43(16):3111-7. PubMed ID: 10956219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of a photolabile ligand for the endothelin-A receptor of endothelin.
    Tessier S; Langlois C; Brkovic A; Coupal M; De Léan A; Fournier A
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S53-4. PubMed ID: 11078334
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The receptor binding affinity of monocyclic [Ala3,Xaa11]endothelin-1 analogs correlates with inducible helix length.
    Andersen NH; Harris SM; Lee VG; Liu EC; Moreland S; Hunt JT
    Bioorg Med Chem; 1995 Feb; 3(2):113-24. PubMed ID: 7796045
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The current endothelin receptor classification: time for reconsideration?
    Bax WA; Saxena PR
    Trends Pharmacol Sci; 1994 Oct; 15(10):379-86. PubMed ID: 7809954
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and structure-activity relationships of potent and orally active sulfonamide ETB selective antagonists.
    Kanda Y; Kawanishi Y; Oda K; Sakata T; Mihara SI; Asakura K; Kanemasa T; Ninomiya M; Fujimoto M; Konoike T
    Bioorg Med Chem; 2001 Apr; 9(4):897-907. PubMed ID: 11354672
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.
    Elliott JD; Lago MA; Cousins RD; Gao A; Leber JD; Erhard KF; Nambi P; Elshourbagy NA; Kumar C; Lee JA
    J Med Chem; 1994 May; 37(11):1553-7. PubMed ID: 8201588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.